Shenzhen Jinbei Biotechnology Co., Ltd. – Trademark Portfolio

Entity Type: 99

Shenzhen Jinbei Biotechnology Co., Ltd. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 11 (Environmental Control) — 2 filings in this category. Currently, 1 trademark is registered. Notable registered marks include FLGSK. The owner is based in Nanshan Dist.,Shenzhen.

8A, Haixinge, Huijinghaoyuan, No. 10,

Nanshan Dist.,Shenzhen 518000 , CN

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

FLGSK
FLGSK
Registered 2026
FLGSK
FLGSK
Other 2023

Trademark Classifications

Shenzhen Jinbei Biotechnology Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

11
Environmental Control (2 filings)

Apparatus for lighting, heating, steam generating, cooking, refrigerating, drying

Frequently Asked Questions

How many trademarks does Shenzhen Jinbei Biotechnology Co., Ltd. have?

Shenzhen Jinbei Biotechnology Co., Ltd. has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered.

What trademark classes does Shenzhen Jinbei Biotechnology Co., Ltd. file in?

Shenzhen Jinbei Biotechnology Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 11 (Environmental Control). Class 11 covers apparatus for lighting, heating, steam generating, cooking, refrigerating, drying.

What are Shenzhen Jinbei Biotechnology Co., Ltd.'s most well-known trademarks?

Shenzhen Jinbei Biotechnology Co., Ltd.'s registered trademark portfolio includes well-known marks such as FLGSK. These are among 1 currently registered trademark in the portfolio.

What is Shenzhen Jinbei Biotechnology Co., Ltd.'s trademark registration success rate?

Shenzhen Jinbei Biotechnology Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.